The Growing Influence of Real-World Data and Evidence

Apr 4, 2024 | Blog

Some of the most prominent and visible roles of real-world data (RWD) and real-world evidence (RWE) are regulatory and clinical decision-making and disease research. However, RWD and RWE have been growing in influence in many other areas of healthcare and in regions...

Takeda Hospital Group Joins TriNetX Network to Revolutionize Medical Care in Japan

Mar 19, 2024 | News, Press Releases

Language:   English   |  日本語 (Japanese) Cambridge, MA, March 19, 2024 — Takeda Hospital Group, a leading healthcare provider in Kyoto, Japan Prefecture, has joined the TriNetX, LLC (TriNetX) network. Recognizing the need for tailored treatments based on the distinct...

Detecting Pancreatic Cancer with TriNetX AI: The PDAC Risk Model Breakthrough

Mar 14, 2024 | Blog, Published Research

Powered By TriNetX MIT and BIDMC’s study published by The Lancet introduces PRISM, a model for early pancreatic cancer risk, using a database of over 156 million de-identified US patients from TriNetX, LLC. PRISM accurately forecasts pancreatic cancer risk 18...

Growing Need for Diversity in Clinical Trials

Feb 13, 2024 | Blog

By Akiko Shimamura, SVP, Trial Design and Optimization, TriNetX Earlier this year, the FDA rejected an application for a new cancer drug because it was based on a trial conducted in China, and the agency ruled it did not represent the U.S. population.[1] In 2021, the...

TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

Jan 31, 2024 | News

Cambridge, MA, January 31, 2024 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, is proud to announce its participation in the CERTAINTY project. CERTAINTY, short for CEllulaR...

TriNetX Recognized on the 2023 Fortune Impact 20 List for Pioneering Advancements in Clinical Trial Diversity

Dec 18, 2023 | News, Press Releases

Cambridge, MA, December 18, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has been named to the 2023 Fortune Impact 20 list. The selection tabs TriNetX as one of the top 20...

TriNetX Showcases Pioneering Role in Advancing Healthcare through Innovative Medical Technologies

Dec 7, 2023 | News, Press Releases

Cambridge, MA, December 7, 2023 — TriNetX, LLC (“TriNetX”) is the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, proudly participating in an important video series, “Connecting the Dots.” The...

Japan’s Osaka Police Hospital to Partner with TriNetX to Increase Clinical Trial Participation and Stimulate Research Opportunities

Nov 8, 2023 | News, Press Releases

Language:   English   |  日本語 (Japanese) Cambridge, MA, November 8, 2023 — Osaka Police Hospital, a core hospital in Osaka, one of Japan’s largest metropolitan areas, has signed a partnership agreement with TriNetX. For over 80 years, Osaka National Police...

Sub-Saharan African Healthcare Organizations Join Public-Private Partnership Pilot to Expand Clinical Research Data and Digital Capacities

Sep 11, 2023 | News

The European & Developing Countries Clinical Trials Partnership (EDCTP), Novartis, and TriNetX, LLC have joined forces to support research capacity development in Sub-Saharan Africa (SSA). Within the framework of EDCTP’s Regional Networks of Excellence, the three...

Shaare Zedek Medical Center Joins the TriNetX Network to Increase Clinical Trial Participation and Attain Access to Global Real-World Data for Investigator-Initiated Research

Jul 19, 2023 | Press Releases

Cambridge, MA, July 19, 2023 — Shaare Zedek Medical Center, Jerusalem’s most active and fastest-growing multi-disciplinary medical center, announced today that it has joined the TriNetX global health research network. Joining the TriNetX Network will enable Shaare...